The non-steroidal anti-inflammatory and antirheumatic medication usage in France is forecasted to decline gradually from 2024 to 2028, measured in Defined Daily Dosage per Thousand Persons Per Day. Compared to 2023, where the series stood at 30.2, the projected decline shows a 2% year-on-year decrease by 2025, with a continuous downward trend averaging a 1.2% annual reduction over the five-year period (CAGR: -1.2%).
Future trends to watch for:
- Innovation in drug formulations to enhance efficacy and safety.
- Growing preference for alternative pain management therapies.
- Potential regulatory changes impacting prescriptions and accessibility.
- Increased focus on preventive care and lifestyle modifications.
